Found: 14
Select item for more details and to access through your institution.
Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade.
- Published in:
- Journal of Pathology, 2023, v. 261, n. 2, p. 169, doi. 10.1002/path.6161
- By:
- Publication type:
- Article
Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury.
- Published in:
- Journal of Pathology, 2022, v. 258, n. 3, p. 236, doi. 10.1002/path.5995
- By:
- Publication type:
- Article
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3965, doi. 10.3390/ijms23073965
- By:
- Publication type:
- Article
Toll-Like Receptors in Acute Kidney Injury.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 816, doi. 10.3390/ijms22020816
- By:
- Publication type:
- Article
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4225, doi. 10.3390/ijms21124225
- By:
- Publication type:
- Article
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3798, doi. 10.3390/ijms21113798
- By:
- Publication type:
- Article
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2632, doi. 10.3390/ijms21072632
- By:
- Publication type:
- Article
The Coming Age of Flavonoids in the Treatment of Diabetic Complications.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 346, doi. 10.3390/jcm9020346
- By:
- Publication type:
- Article
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 272, doi. 10.3390/jcm9010272
- By:
- Publication type:
- Article
Recommendations for implementation of physical training guidelines for patients undergoing chronic hemodialysis.
- Published in:
- Journal of Human Sport & Exercise, 2021, v. 16, p. S1732, doi. 10.14198/jhse.2021.16.Proc4.20
- By:
- Publication type:
- Article
The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice.
- Published in:
- Antioxidants, 2022, v. 11, n. 12, p. 2499, doi. 10.3390/antiox11122499
- By:
- Publication type:
- Article
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Protective Role of Nrf2 in Renal Disease.
- Published in:
- Antioxidants, 2021, v. 10, n. 1, p. 39, doi. 10.3390/antiox10010039
- By:
- Publication type:
- Article
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2961, doi. 10.3390/ijms25052961
- By:
- Publication type:
- Article